Evolution of treatment targets in Crohn's disease

被引：4
|
作者：
White, Jonathan R. [1 ,2 ,3 ]
Jairath, Vipul [4 ,5 ]
Moran, Gordon W. [1 ,2 ,3 ]
机构：
[1] Nottingham Univ Hosp NHS Trust, Nottingham Biomed Res Ctr, Natl Inst Hlth Res, Nottingham, England
[2] Univ Nottingham, Nottingham, England
[3] Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham, England
[4] Western Univ, Div Gastroenterol, Dept Med, London, ON, Canada
[5] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada
来源：
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY | 2019年 / 38-39卷
关键词：
Crohn's disease; Treatment targets; Patient reported outcomes; Clinician reported activity indices; Biomarkers; Endoscopy; Imaging; Histology; INFLAMMATORY-BOWEL-DISEASE; PATIENT-REPORTED OUTCOMES; C-REACTIVE PROTEIN; POST-HOC ANALYSIS; QUALITY-OF-LIFE; FECAL CALPROTECTIN; ULCERATIVE-COLITIS; ACTIVITY INDEX; LEMANN INDEX; MAINTENANCE THERAPY;
D O I：
10.1016/j.bpg.2019.02.001
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Crohn's disease is a chronic relapsing and remitting inflammatory disorder of the gastrointestinal tract, associated with significantly morbidity due to both symptoms and complications that have a considerable detrimental impact on a patient's quality of life. An early treat to target approach with disease modifying agents has been shown to significantly improve long term outcomes, demonstrated by a number of therapeutic targets in a number of modalities. This review will outline the current treatment targets and measures of disease burden in Crohn's disease. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页数：9
相关论文
共 50 条
  • [41] Guselkumab for the treatment of Crohn's disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (04): : 291 - 291
  • [42] Surgical treatment of Crohn's disease
    Fichera, Alessandro
    Michelassi, Fabrizio
    JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (06) : 791 - 803
  • [43] Upadacitinib for the Treatment of Crohn's Disease
    Khanna, Reena
    GASTROENTEROLOGY, 2024, 166 (01) : 211 - 211
  • [44] Ustekinumab for the Treatment of Crohn's Disease
    Keihanian, Sara
    Glover, Sarah
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S490 - S490
  • [45] Progress in treatment for Crohn's disease
    Brzezinski, A
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (03): : 626 - 627
  • [46] Classification and treatment of Crohn's disease
    Sachar, DB
    DRUGS OF TODAY, 2000, 36 : 5 - 8
  • [47] Treatment Perspectives in Crohn's Disease
    Vetter, Marcel
    Neurath, Markus F.
    DIGESTION, 2018, 98 (03) : 135 - 142
  • [48] Surgical treatment of Crohn's disease
    Panis, Y
    ANNALES DE CHIRURGIE, 2002, 127 (01): : 9 - 18
  • [49] Filgotinib for the treatment of Crohn's disease
    Labetoulle, Remi
    Paul, Stephane
    Roblin, Xavier
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (03) : 295 - 300
  • [50] Biosimilar for Treatment of Crohn's Disease
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (06) : 1416 - 1416
12345